menu
    • menu

    Company profile for ChemWerth Inc

    ChemWerth-PSE
    News
    ChemWerth Names New CEO

    18 Jun 2024

    // PRESS RELEASE

    Supply Chain Security If Your API Supply Is Important

    05 Sep 2023

    // PRESS RELEASE

    PharmaTech Outlook Names ChemWerth as a Top Drug Discovery of 2023

    24 May 2023

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Chemwerth

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Booth #12.1F43

    Book a meeting

    envelop Contact Supplier

    Latest Content

    speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Related CompaniesRelated Companies

    About

    Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs to regulated markets worldwide and has exclusive partnerships for new product development, compliance support and secure supply chain logistics. ChemWerth has access to over 500 APIs and more than 30 manufacturing facilities in the US, Europe, India and China. ChemWerth acts as a regulatory agent for over 25 FDA-approved facilities and sells more than 100 products. It has established its presence in 38 countries. In 2020, ChemWerth filed its 500th DMF with the FDA.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ChemWerth IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1764 Litchfield Turnpike Woodbridge, CT 06525
    Telephone
    Telephone
    +1 2033877794
    Client Email
    Email
    jon.moore@chemwerth.com
    Client Website
    Website
    https://chemwerth.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/chemwerth-inc/
    youtube
    YouTube
    http://www.youtube.com/@ChemWerth
    Twitter
    Twitter
    Contact Info
    Others

    ChemWerth Pharmaceutical Technology Co., Ltd. (China)

    20 Floor, BIO Building,
    No. 1326 YanAn Road (West),
    Shanghai 200052 China

    021-52585258

    Email ID:
    chinaoffice@chemwerth.com

     

    ChemWerth (India)

    B-604, 6th Floor
    The Platina
    Near Radisson Hotel
    Gachibowli
    Hyderabad 500 032

    Email ID:
    sales@chemwerth.com

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    INTERVIEW #SpeakPharma

    read-more
    read-more
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    mic“Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 1076

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    read-more

    ReelPharmaFull-Service Generic API CompanyFull-Service Generic API Company

    Full-Service Generic API Company
    Full-Service Generic API Company

    reelFull-Service Generic API Company

    A trusted full-service generic API partner for over four decades with 550+ regulatory filings, global manufacturing, and full regulatory support for accelerated market entry.

    Impressions: 782

    read-more

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-78433.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-27403.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Products Under Development 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-62014.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Nitrosamine & Genotoxic Impurity 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-76959.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    The ChemWerth Advantage 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-50147.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    ChemWerth Celebrates 40 Years in Business

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-23090.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    A New Look at ANDA Approvals

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-1642651741.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    ChemWerth Names New CEO
    ChemWerth Names New CEO

    18 Jun 2024

    // PRESS RELEASE

    https://chemwerth.com/announcement-of-leadership-changes/

    PRESS RELEASE
    18 Jun 2024
    Share Share
    Supply Chain Security If Your API Supply Is Important
    Supply Chain Security If Your API Supply Is Important

    05 Sep 2023

    // PRESS RELEASE

    https://chemwerth.com/supply-chain-security-if-your-api-supply-is-important-you-should-take-5-minutes-to-read-this/

    PRESS RELEASE
    05 Sep 2023
    Share Share
    PharmaTech Outlook Names ChemWerth as a Top Drug Discovery of 2023
    PharmaTech Outlook Names ChemWerth as a Top Drug Discovery of 2023

    24 May 2023

    // PRESS RELEASE

    https://chemwerth.com/pharmatech-outlook-names-chemwerth-as-a-top-drug-discovery-and-development-company-of-2023-2/

    PRESS RELEASE
    24 May 2023
    Share Share
    Peter Werth Recieves Honorary Degree From Housatonic Community College
    Peter Werth Recieves Honorary Degree From Housatonic Community College

    23 May 2023

    // PRESS RELEASE

    https://chemwerth.com/peter-werth-recieves-honorary-degree-from-housatonic-community-college/

    PRESS RELEASE
    23 May 2023
    Share Share
    Woodbridge Pharma Company ChemWerth Eyes Overseas Expansion
    Woodbridge Pharma Company ChemWerth Eyes Overseas Expansion

    21 May 2023

    // PRESS RELEASE

    https://chemwerth.com/woodbridge-pharma-company-chemwerth-eyes-overseas-expansion/

    PRESS RELEASE
    21 May 2023
    Share Share
    ChemWerth Opens Distribution in Mexico and Central America
    ChemWerth Opens Distribution in Mexico and Central America

    18 Apr 2023

    // PRESS RELEASE

    https://chemwerth.com/chemwerth-opens-distribution-in-mexico-and-central-america/

    PRESS RELEASE
    18 Apr 2023
    Share Share

    USDMF

    read-more
    read-more

    01

    Argatroban Hydrate (non-sterile Bulk...

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2019-12-27

    Pay. Date : 2019-12-20

    DMF Number : 20709

    Submission : 2007-07-20

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Arsenic Trioxide

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2015-02-06

    Pay. Date : 2014-04-07

    DMF Number : 26075

    Submission : 2012-05-18

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Azacitidine

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2023-01-26

    Pay. Date : 2022-12-16

    DMF Number : 23416

    Submission : 2009-12-22

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Bromfenac Sodium (sesquihydrate)

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-10-17

    Pay. Date : 2013-07-09

    DMF Number : 24521

    Submission : 2011-05-20

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Clevidipine

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2020-08-04

    Pay. Date : 2020-06-23

    DMF Number : 34556

    Submission : 2020-06-01

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Dexmedetomidine Hcl

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-03-27

    Pay. Date : 2012-12-17

    DMF Number : 24202

    Submission : 2011-12-15

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Dronedarone Hydrochloride Non-steril...

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-11-01

    Pay. Date : 2013-05-07

    DMF Number : 26479

    Submission : 2013-05-02

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Eltrombopag Olamine

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2022-10-25

    Pay. Date : 2022-09-28

    DMF Number : 37269

    Submission : 2022-08-29

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Epinastine Hcl

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21974

    Submission : 2008-12-30

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Esmolol Hcl

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-01-18

    Pay. Date : 2012-12-17

    DMF Number : 16053

    Submission : 2002-06-27

    Status : Active

    Type : II

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Foscarnet sodium hexahydrate

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    Certificate Numbers : R0-CEP 2020-337 - Rev 00

    Status : Valid

    Issue Date : 2023-02-14

    Type : Chemical

    Substance Number : 1520

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Ropivacaine hydrochloride monohydrate

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    Certificate Numbers : R0-CEP 2022-198 - Rev 00

    Status : Valid

    Issue Date : 2023-08-28

    Type : Chemical

    Substance Number : 2335

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Tobramycin, Form I

    U.S.A
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ChemWerth Inc

    Certificate Numbers : R1-CEP 2006-188 - Rev 02

    Status : Withdrawn by Holder

    Issue Date : 2018-10-12

    Type : Chemical

    Substance Number : 645

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Services

    Discover the service capabilities from this company

    Sales, Marketing, Registration

    Discover their expertise for : Sales, Marketing, Registration

    Inspections and registrations

    Check the inspections & registration from this company

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2024-04-03

    ChemWerth Inc

    City : Shanghai

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2024-04-03

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    EPS
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2019-10-18

    Sichuan Credit Chemwerth Pharmaceutical Co. Ltd

    City : Luzhou

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2019-10-18

    Chemwerth Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-06-06

    ChemWerth Inc

    City : Shanghai

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-06-06

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    arrow
    EPS
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-02

    Sichuan Credit Chemwerth Pharmaceutical Co. Ltd

    City : Luzhou

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-02

    Chemwerth Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    arrow
    EPS
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-02

    Sichuan Credit Chemwerth Pharmaceutical Co. Ltd

    City : Luzhou

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-02

    Chemwerth Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43

    District Decision : No Action Indicated

    Inspection End Date : 2015-05-06

    ChemWerth Inc

    City : Shanghai City

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2015-05-06

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    arrow
    EPS
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2012-06-21

    Sichuan Credit Chemwerth Pharmaceutical Co. Ltd

    City : Luzhou

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2012-06-21

    Chemwerth Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    arrow
    CPhI WW Frankfurt
    Booth #12.1F43

    District Decision : No Action Indicated

    Inspection End Date : 2011-04-26

    ChemWerth Inc

    City : Shanghai City

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2011-04-26

    Chemwerth Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    arrow
    EPS
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-08-06

    Sichuan Credit Chemwerth Pharmaceutical Co. Ltd

    City : Luzhou

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-08-06

    Chemwerth Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact ChemWerth Inc and get a quotation

    ChemWerth Inc is a supplier offers 108 products (APIs, Excipients or Intermediates).

    Find a price of Foscarnet Sodium bulk with DMF, CEP offered by ChemWerth Inc

    Find a price of Ropivacaine Hydrochloride bulk with DMF, CEP offered by ChemWerth Inc

    Find a price of Argatroban Monohydrate bulk with DMF offered by ChemWerth Inc

    Find a price of Arsenic Trioxide bulk with DMF offered by ChemWerth Inc

    Find a price of Azacitidine bulk with DMF offered by ChemWerth Inc

    Find a price of Bromfenac Sodium bulk with DMF offered by ChemWerth Inc

    Find a price of Clevidipine bulk with DMF offered by ChemWerth Inc

    Find a price of Dexmedetomidine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Disodium Pamidronate Pentahydrate bulk with DMF offered by ChemWerth Inc

    Find a price of Dronedarone Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Eltrombopag bulk with DMF offered by ChemWerth Inc

    Find a price of Epinastine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Esmolol Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Etomidate bulk with DMF offered by ChemWerth Inc

    Find a price of Fosphenytoin Sodium bulk with DMF offered by ChemWerth Inc

    Find a price of Lapatinib Ditosylate bulk with DMF offered by ChemWerth Inc

    Find a price of Melphalan bulk with DMF offered by ChemWerth Inc

    Find a price of Melphalan Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Methylene Blue bulk with DMF offered by ChemWerth Inc

    Find a price of Milrinone bulk with DMF offered by ChemWerth Inc

    Find a price of Mitomycin bulk with DMF offered by ChemWerth Inc

    Find a price of Nelarabine bulk with DMF offered by ChemWerth Inc

    Find a price of Nepafenac bulk with DMF offered by ChemWerth Inc

    Find a price of Nicardipine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Pemetrexed Disodium bulk with DMF offered by ChemWerth Inc

    Find a price of Penciclovir bulk with DMF offered by ChemWerth Inc

    Find a price of Selenious Acid bulk with DMF offered by ChemWerth Inc

    Find a price of Sodium Nitroprusside bulk with DMF offered by ChemWerth Inc

    Find a price of Spinosyn D bulk with DMF offered by ChemWerth Inc

    Find a price of Tetrabenazine bulk with DMF offered by ChemWerth Inc

    Find a price of Tiagabine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Ziprasidone Mesylate bulk with DMF offered by ChemWerth Inc

    Find a price of Tobramycin bulk offered by ChemWerth Inc

    Find a price of Afoxolaner bulk offered by ChemWerth Inc

    Find a price of Amifostine Trihydrate bulk offered by ChemWerth Inc

    Find a price of Amphotericin B bulk offered by ChemWerth Inc

    Find a price of Atosiban bulk offered by ChemWerth Inc

    Find a price of Avatrombopag Maleate bulk offered by ChemWerth Inc

    Find a price of Avibactam Sodium bulk offered by ChemWerth Inc

    Find a price of Bivalirudin bulk offered by ChemWerth Inc

    Find a price of Brivaracetam bulk offered by ChemWerth Inc

    Find a price of Cabotegravir bulk offered by ChemWerth Inc

    Find a price of Calcium Gluconate bulk offered by ChemWerth Inc

    Find a price of Cefovecin bulk offered by ChemWerth Inc

    Find a price of Cetrorelix Acetate bulk offered by ChemWerth Inc

    Find a price of Clascoterone bulk offered by ChemWerth Inc

    Find a price of Clindamycin Hydrochloride bulk offered by ChemWerth Inc

    Find a price of Cyclosporine bulk offered by ChemWerth Inc

    Find a price of Daptomycin bulk offered by ChemWerth Inc

    Find a price of Edaravone bulk offered by ChemWerth Inc

    Find a price of Elagolix Sodium bulk offered by ChemWerth Inc

    Find a price of Enoxaparin Sodium bulk offered by ChemWerth Inc

    Find a price of Eptifibatide bulk offered by ChemWerth Inc

    Find a price of Etelcalcetide bulk offered by ChemWerth Inc

    Find a price of Etoposide bulk offered by ChemWerth Inc

    Find a price of Fludarabine Phosphate bulk offered by ChemWerth Inc

    Find a price of Fluralaner bulk offered by ChemWerth Inc

    Find a price of Fosaprepitant bulk offered by ChemWerth Inc

    Find a price of Gamithromycin bulk offered by ChemWerth Inc

    Find a price of Ganirelix bulk offered by ChemWerth Inc

    Find a price of Grapiprant bulk offered by ChemWerth Inc

    Find a price of Heparin Sodium bulk offered by ChemWerth Inc

    Find a price of Icatibant Acetate bulk offered by ChemWerth Inc

    Find a price of Ifosfamide bulk offered by ChemWerth Inc

    Find a price of Indocyanine Green bulk offered by ChemWerth Inc

    Find a price of Isavuconazonium Sulfate bulk offered by ChemWerth Inc

    Find a price of Isosulfan Blue bulk offered by ChemWerth Inc

    Find a price of Lanreotide Acetate bulk offered by ChemWerth Inc

    Find a price of Lemborexant bulk offered by ChemWerth Inc

    Find a price of Linaclotide bulk offered by ChemWerth Inc

    Find a price of Liraglutide bulk offered by ChemWerth Inc

    Find a price of Lufenuron bulk offered by ChemWerth Inc

    Find a price of Lurbinectedin bulk offered by ChemWerth Inc

    Find a price of Marbofloxacin bulk offered by ChemWerth Inc

    Find a price of Maropitant bulk offered by ChemWerth Inc

    Find a price of Medetomidine bulk offered by ChemWerth Inc

    Find a price of Melengestrol Acetate bulk offered by ChemWerth Inc

    Find a price of Midostaurin bulk offered by ChemWerth Inc

    Find a price of Milbemycin Oxime bulk offered by ChemWerth Inc

    Find a price of Nitenpyram bulk offered by ChemWerth Inc

    Find a price of Octreotide Acetate bulk offered by ChemWerth Inc

    Find a price of Omadacycline bulk offered by ChemWerth Inc

    Find a price of Pancrelipase bulk offered by ChemWerth Inc

    Find a price of Perampanel bulk offered by ChemWerth Inc

    Find a price of Pergolide Mesylate bulk offered by ChemWerth Inc

    Find a price of Polymyxin B Sulfate bulk offered by ChemWerth Inc

    Find a price of Ponazuril bulk offered by ChemWerth Inc

    Find a price of Rilpivirine bulk offered by ChemWerth Inc

    Find a price of Sarolaner bulk offered by ChemWerth Inc

    Find a price of Semaglutide bulk offered by ChemWerth Inc

    Find a price of Sirolimus bulk offered by ChemWerth Inc

    Find a price of Tacrolimus bulk offered by ChemWerth Inc

    Find a price of Teduglutide bulk offered by ChemWerth Inc

    Find a price of Teriparatide bulk offered by ChemWerth Inc

    Find a price of Terlipressin Acetate bulk offered by ChemWerth Inc

    Find a price of Tirzepatide bulk offered by ChemWerth Inc

    Find a price of Toceranib Phosphate bulk offered by ChemWerth Inc

    Find a price of Treprostinil Diolamine bulk offered by ChemWerth Inc

    Find a price of Treprostinil Sodium bulk offered by ChemWerth Inc

    Find a price of Trilostane bulk offered by ChemWerth Inc

    Find a price of Tulathromycin bulk offered by ChemWerth Inc

    Find a price of Vancomycin Hydrochloride bulk offered by ChemWerth Inc

    Find a price of Vecuronium Bromide bulk offered by ChemWerth Inc

    Find a price of Viloxazine Hydrochloride bulk offered by ChemWerth Inc

    Find a price of Vinorelbine Tartrate bulk offered by ChemWerth Inc

    Find a price of Ziconotide Acetate bulk offered by ChemWerth Inc

    Find a price of Zilpaterol HCl bulk offered by ChemWerth Inc

    Find a price of Ziprasidone Hydrochloride bulk offered by ChemWerth Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search